دورية أكاديمية
How to manage hemostasis in patients with liver disease during interventions.
| العنوان: | How to manage hemostasis in patients with liver disease during interventions. |
|---|---|
| المؤلفون: | Roberts LN; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, Denmark Hill, London, SE5 9RS. |
| المصدر: | Hematology. American Society of Hematology. Education Program [Hematology Am Soc Hematol Educ Program] 2023 Dec 08; Vol. 2023 (1), pp. 274-280. |
| نوع المنشور: | Review; Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 100890099 Publication Model: Print Cited Medium: Internet ISSN: 1520-4383 (Electronic) Linking ISSN: 15204383 NLM ISO Abbreviation: Hematology Am Soc Hematol Educ Program Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Washington, DC : American Society of Hematology Original Publication: Washington, DC : The Society, |
| مواضيع طبية MeSH: | Liver Diseases*/complications , Blood Coagulation Disorders* , Thrombocytopenia*/therapy , Hemostatics*, Humans ; Hemostasis |
| مستخلص: | Patients with advanced chronic liver disease (CLD) often need procedures to both treat and prevent complications of portal hypertension such as ascites or gastrointestinal bleeding. Abnormal results for hemostatic tests, such as prolonged prothrombin time, international normalized ratio, and/or thrombocytopenia, are commonly encountered, raising concerns about increased bleeding risk and leading to transfusion to attempt to correct prior to interventions. However hemostatic markers are poor predictors of bleeding risk in CLD, and routine correction, particularly with fresh frozen plasma and routine platelet transfusions, should be avoided. This narrative review discusses the hemostatic management of patients with CLD using 2 case descriptions. (Copyright © 2023 by The American Society of Hematology.) |
| References: | Hepatology. 2019 Oct;70(4):1336-1348. (PMID: 30762895) J Thromb Haemost. 2020 Mar;18(3):560-570. (PMID: 31667992) Gastroenterology. 2004 Oct;127(4):1123-30. (PMID: 15480990) Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):267-273. (PMID: 38066858) Liver Int. 2021 Aug;41(8):1901-1908. (PMID: 33969607) Liver Transpl. 2005 Aug;11(8):973-9. (PMID: 16035095) Gastroenterology. 2018 Sep;155(3):705-718. (PMID: 29778606) Gastroenterology. 2021 Nov;161(5):1615-1627.e1. (PMID: 34579936) J Thromb Haemost. 2022 Nov;20(11):2713-2714. (PMID: 36271459) J Thromb Haemost. 2022 Jan;20(1):39-47. (PMID: 34661370) Thromb Haemost. 2021 Oct;121(10):1317-1325. (PMID: 33450778) Medicine (Baltimore). 2015 Dec;94(49):e2225. (PMID: 26656363) J Thromb Haemost. 2016 May;14(5):1054-66. (PMID: 26833718) Liver Int. 2018 Nov;38(11):1988-1996. (PMID: 29768734) Liver Int. 2018 Aug;38(8):1437-1441. (PMID: 29393567) Br J Haematol. 2018 Apr;181(1):54-67. (PMID: 29527654) Am J Gastroenterol. 2018 Mar;113(3):368-375. (PMID: 29257146) Hepatol Commun. 2023 Apr 26;7(5):. (PMID: 37102761) J Vasc Interv Radiol. 2019 Aug;30(8):1168-1184.e1. (PMID: 31229333) Emerg Med Australas. 2023 Feb;35(1):89-96. (PMID: 35993256) Thromb Haemost. 2022 Jun;122(6):1006-1016. (PMID: 34638152) J Thromb Haemost. 2019 Nov;17(11):1966-1972. (PMID: 31436045) Dig Dis Sci. 2022 Nov;67(11):5290-5299. (PMID: 35122595) Eur J Intern Med. 2017 Mar;38:79-82. (PMID: 27989373) Hepatology. 2008 May;47(5):1604-14. (PMID: 18393319) Platelets. 2022 Jan 2;33(1):66-72. (PMID: 33459573) Hepatol Commun. 2020 Dec 12;5(2):272-282. (PMID: 33553974) Transplantation. 2021 Aug 1;105(8):1771-1777. (PMID: 32852404) Gut. 1974 Feb;15(2):99-101. (PMID: 4820643) J Hepatol. 2020 Jan;72(1):85-94. (PMID: 31536747) J Hepatol. 2023 May;78(5):1037-1047. (PMID: 36708812) Dig Liver Dis. 2022 Nov;54(11):1520-1526. (PMID: 35474168) Res Pract Thromb Haemost. 2022 May 22;6(4):e12724. (PMID: 36204546) Liver Int. 2021 Oct;41(10):2455-2466. (PMID: 34219335) J Thromb Haemost. 2021 Jan;19(1):85-95. (PMID: 33006808) J Thromb Haemost. 2022 Dec;20(12):2786-2796. (PMID: 36128757) J Hepatol. 2021 Mar;74(3):578-583. (PMID: 32918956) Dig Dis Sci. 1981 May;26(5):388-93. (PMID: 7249879) Dig Liver Dis. 2021 Nov;53(11):1396-1403. (PMID: 34373229) Lancet. 2020 Jun 20;395(10241):1927-1936. (PMID: 32563378) Chest. 2022 Nov;162(5):e207-e243. (PMID: 35964704) Ann Pharmacother. 2023 Oct;57(10):1178-1184. (PMID: 36803019) J Hepatol. 2022 May;76(5):1151-1184. (PMID: 35300861) Hepatology. 2021 Jan;73(1):366-413. (PMID: 33219529) N Engl J Med. 2012 Aug 23;367(8):716-24. (PMID: 22913681) J Hepatol. 2002 Oct;37(4):463-70. (PMID: 12217599) J Thromb Haemost. 2021 Mar;19(3):664-676. (PMID: 33219597) Liver Transpl. 2005 Aug;11(8):895-900. (PMID: 16035081) Hepatology. 2016 Aug;64(2):556-68. (PMID: 27124745) |
| المشرفين على المادة: | 0 (Hemostatics) |
| تواريخ الأحداث: | Date Created: 20231209 Date Completed: 20231216 Latest Revision: 20240215 |
| رمز التحديث: | 20240215 |
| مُعرف محوري في PubMed: | PMC10727050 |
| DOI: | 10.1182/hematology.2023000480 |
| PMID: | 38066857 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1520-4383 |
|---|---|
| DOI: | 10.1182/hematology.2023000480 |